Type 1

Welcome At the University of Florida Diabetes Institute, we are working together for a diabetes-free world.

The New York Times recently published a feature on the challenges children with type 1 diabetes face in school- read a collection of several parents’ stories here.

JDRF recently posted two new opportunities. The first is titled Overcoming Obstacles to Achieving Immune Tolerance in Type 1 Diabetes. From JDRF: “JDRF is soliciting letters of intent for the identification of key barriers in the way of therapeutically restoring immune tolerance in type 1 diabetes…

UFDI Director Mark Atkinson, Ph.D. and Insulin for Life found a way to recycle unused diabetes supplies.

JDRF and the American Diabetes Association, announced today that a new classification approach for staging T1D in its earliest presymptomatic stages would be published in the September 24th online version of Diabetes Care.

Call it the scientist’s version of happy hour: A new, four-drug cocktail has shown a novel ability to reverse established Type 1 diabetes in some mice, University of Florida Health researchers have found.

Dr. Haller currently serves as the Principal Investigator for the TrialNet ATG/GCSF study funded collaboratively by the NIH, the Helmsley Trust, and Sanofi.

UFDI Investigator Patrick Concannon, Ph.D. UFDI Investigator Patrick Concannon, Ph.D. and University of Virginia School of Medicine Investigator Stephen S. Rich recently published two papers on their findings from the Type 1 Diabetes Genetics Consortium (T1DGC). Summary of…

Giovanna Beauchamp, M.D. and Michael J. Haller, M.D., M.S. recently released a review of several type 1 diabetes (T1D) prevention studies in Current Diabetes Reports. The publication, titled ‘Can We Prevent Type 1 Diabetes?,’ highlights recent and ongoing efforts to understand the…